Cogent Biosciences, Inc. (COGT)
35.41
+2.03
(+6.08%)
USD |
NASDAQ |
Mar 23, 16:00
35.40
0.00 (0.00%)
After-Hours: 20:00
Cogent Biosciences Shareholders Equity (Quarterly) : 636.37M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Terns Pharmaceuticals, Inc. | 284.07M |
| Nuvalent, Inc. | 1.248B |
| Sarepta Therapeutics, Inc. | 1.141B |
| BridgeBio Pharma, Inc. | -2.087B |
| Mirum Pharmaceuticals, Inc. | 314.69M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 937.61M |
| Total Liabilities (Quarterly) | 301.24M |
| Debt to Equity Ratio | 0.3752 |
| Current Ratio | 14.23 |
| Net Debt Paydown Yield | -0.77% |